The ALTERNATE trial: Assessing a biomarker driven strategy for the treatment of post-menopausal women with Er+/Her2- invasive breast cancer

Vera Jean Suman, Matthew J. Ellis, Cynthia X. Ma

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'The ALTERNATE trial: Assessing a biomarker driven strategy for the treatment of post-menopausal women with Er+/Her2- invasive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences